Inspire Financial Statements From 2010 to 2026

INSP Stock  USD 59.53  0.25  0.42%   
Analyzing historical trends in various income statement and balance sheet accounts from Inspire Medical's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Inspire Medical's valuation are summarized below:
Gross Profit
778.8 M
Profit Margin
0.1595
Market Capitalization
1.7 B
Enterprise Value Revenue
1.5634
Revenue
912 M
There are currently one hundred twenty fundamental trends for Inspire Medical Systems that can be evaluated and compared over time across competitors. Investors and active traders are advised to confirm Inspire Medical's regular fundamental performance against the performance between 2010 and 2026 to make sure the trends are evolving in the right direction. As of 02/22/2026, Enterprise Value is likely to grow to about 2.6 B, while Market Cap is likely to drop slightly above 2.4 B.

Inspire Medical Total Revenue

957.58 Million

Check Inspire Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inspire Medical's main balance sheet or income statement drivers, such as Interest Income of 18.4 M, Depreciation And Amortization of 14.7 M or Interest Expense of 130.2 K, as well as many indicators such as Price To Sales Ratio of 2.82, Dividend Yield of 0.0 or PTB Ratio of 3.29. Inspire financial statements analysis is a perfect complement when working with Inspire Medical Valuation or Volatility modules.
  
Build AI portfolio with Inspire Stock
Check out the analysis of Inspire Medical Correlation against competitors.

Inspire Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding24.8 M29.8 M19.7 M
Slightly volatile
Total Assets952.7 M907.3 M293.2 M
Slightly volatile
Short and Long Term Debt Total27.8 M32.2 M22 M
Slightly volatile
Other Current Liabilities60.2 M57.3 M18.4 M
Slightly volatile
Total Current Liabilities100.9 M96.1 M33.7 M
Slightly volatile
Other Liabilities112.8 K167.9 K90.9 K
Slightly volatile
Property Plant And Equipment Net127.5 M121.4 M27.7 M
Slightly volatile
Accounts Payable18.9 M36.6 M11.6 M
Slightly volatile
Cash156.5 M104.8 M95.3 M
Slightly volatile
Non Current Assets Total339.8 M323.7 M59.7 M
Slightly volatile
Non Currrent Assets Other18.1 M17.3 M4.6 M
Slightly volatile
Long Term Debt21.8 M18.2 M16.5 M
Slightly volatile
Cash And Short Term Investments272.2 M308.3 M164 M
Slightly volatile
Net Receivables125.7 M119.7 M34.5 M
Slightly volatile
Common Stock Total Equity22.6 K33.4 K15.5 K
Slightly volatile
Long Term Debt Total21.8 M18.2 M16.5 M
Slightly volatile
Liabilities And Stockholders Equity952.7 M907.3 M293.2 M
Slightly volatile
Non Current Liabilities Total25.1 M30.1 M19.3 M
Slightly volatile
Capital Surpluse990.6 M943.4 M356.3 M
Slightly volatile
Inventory152.6 M145.3 M28.5 M
Slightly volatile
Other Current Assets5.3 M10.4 M3.3 M
Slightly volatile
Other Stockholder Equity592.4 M927.2 M354 M
Slightly volatile
Total Liabilities72.2 M126.2 M49.8 M
Slightly volatile
Property Plant And Equipment Gross154.4 M147.1 M32 M
Slightly volatile
Short and Long Term Debt10.6 M10.6 M7.4 M
Slightly volatile
Preferred Stock Total Equity117.3 M137 M109.8 M
Slightly volatile
Total Current Assets361.1 M583.7 M218.7 M
Slightly volatile
Short Term Debt3.9 M2.2 M3.8 M
Very volatile
Common Stock25.6 K29 K15.6 K
Slightly volatile
Property Plant Equipment20.8 M19.8 M7.4 M
Slightly volatile
Net Invested Capital417.9 M781.2 M233.1 M
Slightly volatile
Net Working Capital348.3 M487.6 M195.1 M
Slightly volatile
Capital Stock30.1 K29 K25.5 K
Slightly volatile
Other Assets183.8 K193.5 K649.7 K
Very volatile
Non Current Liabilities Other98.8 K104 K934.3 K
Slightly volatile
Capital Lease Obligations20.4 M32.2 M11.2 M
Slightly volatile

Inspire Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income18.4 M17.5 M5.8 M
Slightly volatile
Depreciation And Amortization14.7 M14 M2.6 M
Slightly volatile
Selling General Administrative655.9 M624.6 M164.5 M
Slightly volatile
Selling And Marketing Expenses114.6 M109.1 M42.3 M
Slightly volatile
Total Revenue957.6 M912 M251.7 M
Slightly volatile
Gross Profit817.7 M778.8 M212.9 M
Slightly volatile
Other Operating Expenses904.1 M861 M266.5 M
Slightly volatile
Research Development108.3 M103.2 M38.2 M
Slightly volatile
Cost Of Revenue139.9 M133.2 M38.8 M
Slightly volatile
Total Operating Expenses764.2 M727.8 M227.6 M
Slightly volatile
Reconciled Depreciation14.7 M14 M2.6 M
Slightly volatile

Inspire Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation136.8 M130.3 M33.3 M
Slightly volatile
Begin Period Cash Flow133.8 M150.2 M89 M
Slightly volatile
Depreciation14.7 M14 M2.6 M
Slightly volatile
Capital Expenditures40.4 M38.5 M9.6 M
Slightly volatile
End Period Cash Flow143.5 M104.8 M96.4 M
Slightly volatile
Change To Netincome62.1 M59.1 M19.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.822.970123.9121
Slightly volatile
Days Sales Outstanding58.5847.90451.1689
Slightly volatile
Stock Based Compensation To Revenue0.140.130.077
Slightly volatile
Capex To Depreciation2.572.75843.0778
Slightly volatile
EV To Sales2.752.890416.8249
Slightly volatile
Inventory Turnover0.870.91691.8612
Slightly volatile
Days Of Inventory On Hand418398252
Pretty Stable
Payables Turnover2.273.64352.979
Slightly volatile
Sales General And Administrative To Revenue0.670.620.5376
Slightly volatile
Research And Ddevelopement To Revenue0.110.11310.4329
Slightly volatile
Capex To Revenue0.02230.04220.0321
Slightly volatile
Cash Per Share7.610.49646.2266
Slightly volatile
Days Payables Outstanding145100125
Slightly volatile
Current Ratio6.566.07625.8042
Slightly volatile
Receivables Turnover5.637.61947.2444
Slightly volatile
Graham Number34.0254.436332.2179
Slightly volatile
Capex Per Share1.381.31090.3385
Slightly volatile
Revenue Per Share32.6131.05269.0402
Slightly volatile
Interest Debt Per Share1.321.09951.2677
Slightly volatile
Debt To Assets0.03370.03540.5702
Slightly volatile
Operating Cycle468446303
Pretty Stable
Days Of Payables Outstanding145100125
Slightly volatile
Ebt Per Ebit0.851.28931.0535
Very volatile
Long Term Debt To Capitalization0.01640.01720.9677
Slightly volatile
Total Debt To Capitalization0.03760.03950.8081
Slightly volatile
Quick Ratio8.434.56365.4323
Slightly volatile
Net Income Per E B T2.322.21351.1495
Slightly volatile
Cash Ratio1.041.09122.6797
Slightly volatile
Days Of Inventory Outstanding418398252
Pretty Stable
Days Of Sales Outstanding58.5847.90451.1689
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.90.67090.8845
Slightly volatile
Fixed Asset Turnover7.147.51218.808
Slightly volatile
Debt Ratio0.03370.03540.5702
Slightly volatile
Price Sales Ratio2.822.970123.9121
Slightly volatile
Asset Turnover0.631.00510.9462
Slightly volatile
Gross Profit Margin0.650.85390.7542
Slightly volatile

Inspire Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.4 B2.4 B2.2 B
Slightly volatile
Enterprise Value2.6 B2.4 B2.1 B
Slightly volatile

Inspire Fundamental Market Drivers

Forward Price Earnings49.7512
Cash And Short Term Investments308.3 M

Inspire Upcoming Events

6th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Inspire Medical Financial Statements

Inspire Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Inspire Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Inspire Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Inspire Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-745.2 K-782.5 K
Total Revenue912 M957.6 M
Cost Of Revenue133.2 M139.9 M
Stock Based Compensation To Revenue 0.13  0.14 
Sales General And Administrative To Revenue 0.62  0.67 
Research And Ddevelopement To Revenue 0.11  0.11 
Capex To Revenue 0.04  0.02 
Revenue Per Share 31.05  32.61 
Ebit Per Revenue 0.06  0.06 

Pair Trading with Inspire Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inspire Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inspire Medical will appreciate offsetting losses from the drop in the long position's value.

Moving together with Inspire Stock

  0.66GLH Global Health Earnings Call TomorrowPairCorr
  0.77XE NIGHTINGALE HEALTHPairCorr
  0.76DOCS DoximityPairCorr

Moving against Inspire Stock

  0.7ALMDT MediantechnPairCorr
  0.67FDBK Feedback PLC Earnings Call TomorrowPairCorr
  0.65AJ91 DocCheck AGPairCorr
The ability to find closely correlated positions to Inspire Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inspire Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inspire Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inspire Medical Systems to buy it.
The correlation of Inspire Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inspire Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inspire Medical Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inspire Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Inspire Stock Analysis

When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.